1-minute postexercise pressure of >30 mmHg, and/or 5-minute postexercise pressure of >20 mmHg are accepted criteria for diagnosis. 3 Definitive treatment for CECS is fasciotomy, with high success rate when followed by an extensive rehabilitation program. 4 However, persistent exertional pain and recurrence are reported complications after surgery. 4 Morphea is a sclerosing dermopathy characterized by single or multiple asymptomatic indurated skin plaques, usually affecting one side of the body and accompanied by discoloration and atrophy. Deep morphea can be associated with subcutaneous tissue atrophy, contractures, and cosmetic sequelae of skin involvement, but significant internal organ involvement is rare. 5 To our knowledge, this is the first reported case of unilateral forearm CECS driven by underlying deep morphea, in a nonathlete patient. The diagnosis of CECS requires high vigilance for symptoms which warrant specialized evaluation. Prompt intervention can avoid disability and deterioration of patient's quality of life. Better understanding of CECS affecting the upper extremity and CECS in nonathletes is needed. It is critical to educate physicians and trainees, beyond those in musculoskeletal or sports medicine, about CECS to avoid delayed or missed diagnosis of this poorly recognized disease entity.